Research Projects & Grants

For Profit Organization

  • Systemic Lupus Erythematosus (SLE) prospective observational cohort study (SPOCS): Prospective observational cohort of patients with moderate-to-severe SLE to characterize cross-sectional and longitudinal disease activity, treatment patterns and effectiveness, outcomes and comorbidities, healthcare resource utilization, and the impact of SLE on quality of life by type I interferon gene expression, Role: Investigator, AstraZeneca (UK HQ), (10/2022 - 10/2023) Status: Completed
  • A randomized, double-blind, parallel-group, multicenter study of secukinumab to compare 300 mg and 150 mg at week 52 in patients with Ankylosing Spondylitis who are randomized to dose escalation after not achieving inactive disease during an initial 16 week open-label treatment with secukinumab 150 mg (ASLeap), Role: PI, Novartis Pharmaceuticals Corporation, (07/2020 - 07/2021) Status: Completed
  • Care for Lupus: clinical laboratory assessments and recommendations for Lupus, Role: PI, Exagen Diagnostics, Inc., (08/2018 - 08/2019) Status: Completed

Internal

  • Loma Linda University Medical System Large Vessel Vasculitis Registry, Retrospective single center review, Role: PI, LLU Dept. of Medicine, (04/2021) Status: Approved
  • Behcet’s Disease in Hispanic Americans, Role: PI, LLU Dept. of Medicine, (02/2021) Status: Approved
  • SARS-CoV-related Cytokine Release Syndrome (CoV-CRS): Identification and Evaluation of treatment response to biologic therapy, Role: Investigator, LLU Dept. of Medicine, (07/2020) Status: Approved
  • Association between anti-tumor necrosis factor alpha therapy and autoimmune Hepatitis: Retrospective, single center review, Role: PI, LLU Dept. of Medicine, (09/2019) Status: Completed
  • The role of B cells in systemic lupus erythematosus patients, Role: Investigator, LLU Transplantation Institute, (09/2018 - 09/2019) Status: Completed